Ann M. Leen - 12 Nov 2021 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Chief Scientific Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
12 Nov 2021
Net transactions value
-$465,559
Form type
4
Filing time
16 Nov 2021, 17:36:41 UTC
Previous filing
10 May 2021
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $317,628 -14,266 -0.62% $22.26* 2,294,876 12 Nov 2021 See Footnote F1, F2, F3
transaction ALVR Common Stock Sale $11,588 -500 -0.02% $23.18* 2,294,376 12 Nov 2021 See Footnote F1, F3, F4
transaction ALVR Common Stock Sale $134,167 -6,122 -0.27% $21.92* 2,288,254 15 Nov 2021 See Footnote F1, F3, F5
transaction ALVR Common Stock Sale $2,176 -100 -0% $21.76* 2,288,154 16 Nov 2021 See Footnote F1, F3
holding ALVR Common Stock 28,000 12 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.81 to $22.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.99 to $23.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.75 to $22.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.